Music Therapy: A Cognitive Boost for Alzheimer’s Patients

Introduction

Music therapy (MT) is gaining traction as a non-pharmacological means to support cognitive and behavioral health in Alzheimer’s disease (AD). This systematic review (PMCID: PMC10041788) analyzes how MT affects key domains such as global cognition, memory, language, processing speed, verbal fluency, and attention in AD patients.choosingtherapy.com+10pmc.ncbi.nlm.nih.gov+10nchr.elsevierpure.com+10


🧪 Methods

  • Search scope: PubMed, Cochrane Library, HINARI (Jan 2012–Jun 2022)
  • Inclusion: Randomized controlled trials comparing MT vs. standard care or non-musical interventions
  • Studies included: 8 RCTs, 689 participants aged ~60–87 years
  • Locations: Europe (France, Spain), Asia (China, Japan), USA
  • Quality: 6 of 8 trials rated high qualityresearchgate.net+3pmc.ncbi.nlm.nih.gov+3ouci.dntb.gov.ua+3ouci.dntb.gov.ua

📊 Key Findings

  1. Global Cognitive Function
  2. Memory & Verbal Fluency
  3. Attention & Processing Speed
  4. Impact of Active Music Interventions (AMI)
  5. Music Type Matters
    • Familiar or classical tunes (e.g., Bach, Mozart) enhanced cognitive response, supporting personalized, preference-based MT artofit.org.

🧭 Conclusions & Implications


🎯 Practical Takeaways

  • Clinicians & caregivers may incorporate music therapy as a complementary method for memory, speech, and attention enhancement in AD.
  • Individualized music based on the patient’s history increases engagement and cognitive benefit.
  • Future studies should aim to clarify the most effective formats, session durations, and music genres for diverse AD populations.

Bir yanıt yazın

E-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir